logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Kidney Transplantation

    FiltersReset Filters
    11 results

    • azathioprine

      (Azathioprine)
      Ascend Laboratories, LLC
      Usage: Azathioprine is indicated as an adjunct for preventing rejection in renal homotransplantation and for managing active rheumatoid arthritis to reduce signs and symptoms. Its combined use with other disease-modifying anti-rheumatic drugs has not been studied and is not recommended.

    • azathioprine

      (Azathioprine)
      Glenmark Pharmaceuticals, Inc
      Usage: Azathioprine is indicated as an adjunct for preventing rejection in renal transplants and for managing active rheumatoid arthritis to reduce signs and symptoms. Its use with disease-modifying anti-rheumatic drugs has not been studied, and concurrent use is not recommended.

    • cellcept

      (Mycophenolate Mofetil)
      Genentech, Inc.
      Usage: CELLCEPT (mycophenolate mofetil) is indicated for the prevention of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, used alongside other immunosuppressants.

    • cyclosporine

      (Cyclosporine)
      Strides Pharma Science Limited
      Usage: Cyclosporine capsules (modified) are indicated for the prophylaxis of organ rejection in kidney, liver, and heart transplants, treatment of severe rheumatoid arthritis unresponsive to methotrexate, and severe plaque psoriasis in adults who have not adequately responded to systemic therapies or cannot tolerate them.

    • cyclosporine

      (Cyclosporine)
      Teva Pharmaceuticals USA, Inc.
      Usage: Cyclosporine capsules, USP MODIFIED are indicated for organ rejection prophylaxis in kidney, liver, and heart transplants, treatment of severe active rheumatoid arthritis unresponsive to methotrexate, and severe plaque psoriasis in adults who failed previous systemic therapies or cannot tolerate them.

    • gengraf

      (Cyclosporine)
      AbbVie Inc.
      Usage: Gengraf® (cyclosporine oral solution, USP [MODIFIED]) is indicated for the prevention of organ rejection in kidney, liver, and heart transplants, as well as for treating severe active rheumatoid arthritis unresponsive to methotrexate and severe plaque psoriasis in adults who have failed prior systemic therapies.

    • mycophenolate mofetil

      (Mycophenolate Mofetil)
      Camber Pharmaceuticals, Inc.
      Usage: Mycophenolate mofetil capsules are indicated for preventing organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, in combination with other immunosuppressive agents.

    • mycophenolate mofetil

      (MYCOPHENOLATE MOFETIL)
      Advagen Pharma Limited
      Usage: Mycophenolate mofetil (MMF) is indicated for the prophylaxis of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, in combination with other immunosuppressants.

    • mycophenolate mofetil

      (Mycophenolate Mofetil)
      Amneal Pharmaceuticals NY LLC
      Usage: Mycophenolate mofetil for oral suspension is indicated for preventing organ rejection in adult and pediatric patients (3 months and older) undergoing allogeneic kidney, heart, or liver transplants, in conjunction with other immunosuppressive therapies.

    • mycophenolate mofetil

      (Mycophenolate Mofetil)
      Lannett Company, Inc.
      Usage: Mycophenolate mofetil (MMF) is indicated for the prevention of organ rejection in adult and pediatric recipients aged 3 months and older undergoing allogeneic kidney, heart, or liver transplants, used in conjunction with other immunosuppressants.